Previous 10 | Next 10 |
2024-03-20 16:49:21 ET More on Fusion Pharmaceuticals What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook Biggest stock movers today: SMCI, JWN, FUSN, NCMI, crypto stocks and ...
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates Canada NewsWire Company recently announced definitive agreement to be acquired by AstraZeneca FPI-2265 Phase 2/3 registrational program for...
NEW YORK, NY / ACCESSWIRE / March 20, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Fusion Pharmaceuticals Inc. (NASDAQ:...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 9.8% to $0.133 on volume of 209,262,975 shares Ontrak Inc. (OTRK) rose 131.6% to $0.44 on volume of 206,699,914 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.7% to $3.65 on volume of 1...
2024-03-19 13:15:03 ET Summary AstraZeneca is acquiring Fusion Pharmaceuticals for up to $2.4 billion to expand its presence in the radiopharmaceuticals market. The acquisition includes Fusion's late-stage radiopharmaceutical candidate, FPI-2265, a potential treatment of metastati...
2024-03-19 12:48:26 ET More on Mid-day movers & stocks. Ontrak Health announces continuing expansion with Sentara Health Sarcos Technology and Robotics says co-founder Ben Wolff to become CEO Financial information for Aptorum Group Seeking Alpha’s ...
2024-03-19 12:31:34 ET More on Actinium Pharmaceuticals Actinium Pharmaceuticals: Closer To Realizing Its Potential (Rating Upgrade) Actinium shares surge on promising data for AML radiotherapy candidate Actinium, Fusion stocks rally on $4.1B RayzeBio takeover deal ...
2024-03-19 10:00:51 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...
A look at the top 10 most actives in the United States Ontrak Inc. (OTRK) rose 214.5% to $0.5975 on volume of 79,666,583 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.0% to $3.7703 on volume of 36,416,698 shares Enveric Biosciences Inc. (ENVB) rose 35.5% to $1.49 on vol...
Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) traded at a new 52-week high today and are currently trading at $21.01. So far today, approximately 17.84M shares have been exchanged, as compared to an average 30-day volume of 1.07M shares. Fusion Pharmaceuticals Inc., a clinical-stage on...
News, Short Squeeze, Breakout and More Instantly...
Fusion Pharmaceuticals Inc. Company Name:
FUSN Stock Symbol:
NASDAQ Market:
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the ...
Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer Canada NewsWire AlphaBreak is a Phase 2/3 registrational program for FPI-2265 in patients with metastati...
Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates Canada NewsWire Presented interim data from TATCIST trial of FPI-2265 in mCRPC at the 2024 American Association for Cancer Research (AACR) Annual Meeting Si...